Results 151 to 160 of about 46,091 (305)

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune‐mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital‐based claims database

open access: yesJournal of Diabetes Investigation, EarlyView.
In this target trial emulation of patients with immune‐mediated inflammatory diseases and type 2 diabetes, SGLT2 inhibitor initiation was not associated with a clear increase in UTI risk versus metformin, including across immunosuppressive therapy strata.
Hiroshi Tsushima   +6 more
wiley   +1 more source

Incidence of P200 pemphigoid: A nationwide study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The anti‐LAMB4 cell‐based immunoassay is a new serological technique that is far superior to dermal immunoblotting for detecting autoantibodies directed against the P200 protein. This method allows a re‐evaluation of the incidence of P200 pemphigoid, which appears to be considerably more frequent than epidermolysis bullosa acquisita.
Fabienne Jouen   +7 more
wiley   +1 more source

The role of acquired host immunity in periodontal diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract The aim of this narrative review is to relate the contribution of European researchers to the complex topic of the host immune system in periodontal disease, focusing on acquired immunity. Other chapters in this volume will address the genetics and autoantibody responses and other forms of immunity to periodontal disease.
Denis F. Kinane   +2 more
wiley   +1 more source

Eosinophilia in the Tropics: Should Empirical Anthelmintic Treatment Be Considered Standard Practice? A Prospective Cohort Study

open access: yesTropical Medicine &International Health, EarlyView.
ABSTRACT Background Eosinophilia is a common clinical finding with diverse etiologies. Helminthiasis is a major aetiology in tropical regions, but data from haematology consultation services at tertiary centres in endemic settings are limited. Objectives To determine the prevalence of helminthiasis among patients with eosinophilia at a tropical ...
Smith Kungwankiattichai   +3 more
wiley   +1 more source

Różne oblicza choroby IgG4-zależnej

open access: yes, 2016
  Choroba IgG4-zależna (IgG4-RD, IgG4-related disease) jest stosunkowo niedawno opisaną jednostką chorobową o nieznanej etiologii i patogenezie. Charakteryzuje się przewlekłym stanem zapalnym prowadzącym do włóknienia zajętych narządów i upośledzenia ich
Masiak, Anna; Klinika Chorób Wewnętrznych, Chorób Tkanki Łącznej i Geriatrii, Gdański Uniwersytet Medyczny   +1 more
core  

Clinical implications of imlifidase interference in antibody screening and transfusion management

open access: yesTransfusion, EarlyView.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani   +2 more
wiley   +1 more source

IgG4‐Related Sacroiliitis [PDF]

open access: yesArthritis & Rheumatology, 2016
N, Possemato   +4 more
openaire   +2 more sources

IgG4-Related Orbital Disease

open access: yes
IgG4 related disease (IgG4-RD) is a systemic fibro-inflammatory disease leading to tumour-like infiltrations potentially affecting all parts of the human body, including the periorbital tissues (IgG4-ROD).
Savino G.
core   +1 more source

Comparison of four different in vitro assays for prediction of potential RBC antibody clinical significance

open access: yesTransfusion, EarlyView.
Abstract Background The monocyte monolayer assay (MMA) uses monocytes, but it is known that antibody‐mediated hemolysis occurs in macrophages. Whether the use of macrophages would improve the predictive capacity of the MMA is unclear. Also, it is unclear if RBC alloantibodies contribute to hemolysis via antibody‐dependent cellular cytotoxicity (ADCC ...
Yeniley Ruiz Noa   +6 more
wiley   +1 more source

IgG4‐Related Disease Overlapping With Anti‐Acetylcholine Receptor Antibody–Positive Myasthenia Gravis

open access: yesClinical and Experimental Neuroimmunology, Volume 17, Issue 3, August 2026.
ABSTRACT Background IgG4‐related disease (IgG4‐RD) is a systemic, immune‐mediated, fibroinflammatory disorder with multiorgan involvement and variable clinical presentation, often creating diagnostic difficulty. Myasthenia gravis (MG) is an antibody‐mediated autoimmune disorder of the neuromuscular junction, most commonly associated with anti ...
Yumiko Yoshida   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy